| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/03602532.2011.560606 |
| P698 | PubMed publication ID | 21428696 |
| P2093 | author name string | Enrico Garattini | |
| Mineko Terao | |||
| P2860 | cites work | Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. | Q51967988 |
| Prognostically useful gene-expression profiles in acute myeloid leukemia. | Q51999490 | ||
| Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. | Q52022087 | ||
| Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. | Q52089307 | ||
| Whole genome analysis for liver metastasis gene signatures in colorectal cancer. | Q53539819 | ||
| Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. | Q54566397 | ||
| Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. | Q54631582 | ||
| Purification, crystallization and preliminary X-ray diffraction studies of xanthine dehydrogenase and xanthine oxidase isolated from bovine milk. | Q55034413 | ||
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression | Q57693549 | ||
| Metabolism of methotrexate and γ-tert-butyl methotrexate by human leukemic cells in culture and by hepatic aldehyde oxidase in vitro | Q58483860 | ||
| Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma | Q24646856 | ||
| Purification and mechanism of human aldehyde oxidase expressed in Escherichia coli | Q24649235 | ||
| Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion | Q24650500 | ||
| Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia | Q24675399 | ||
| Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada | Q24682265 | ||
| A DNA microarray survey of gene expression in normal human tissues | Q24797220 | ||
| Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data | Q24805313 | ||
| Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays | Q28185685 | ||
| Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma | Q28240852 | ||
| Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia | Q28248216 | ||
| X chromosomal abnormalities in basal-like human breast cancer | Q28296876 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Oxidation of Selected Pteridine Derivatives by Mammalian Liver Xanthine Oxidase and Aldehyde Oxidase | Q28320846 | ||
| The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysis | Q28512901 | ||
| Increase of nicotinamide methyltransferase and N1-methyl-nicotinamide oxidase activities in the livers of the rats administered alkylating agents | Q28571296 | ||
| Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1 | Q28591706 | ||
| Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
| Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Q29615823 | ||
| Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide | Q29619956 | ||
| Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma | Q30014823 | ||
| Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes | Q30836033 | ||
| Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data | Q30983130 | ||
| Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme | Q31114297 | ||
| Molecular cloning of retinal oxidase/aldehyde oxidase cDNAs from rabbit and mouse livers and functional expression of recombinant mouse retinal oxidase cDNA in Escherichia coli | Q31813052 | ||
| Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1 | Q31813076 | ||
| Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase | Q33180688 | ||
| The aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase homologue 3, a novel member of the molybdo-flavoenzyme family with selective expression in the olfactory mucosa. | Q33207069 | ||
| Avian and canine aldehyde oxidases. Novel insights into the biology and evolution of molybdo-flavoenzymes | Q33242124 | ||
| Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers | Q33285000 | ||
| Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | Q33320978 | ||
| Stromal gene expression predicts clinical outcome in breast cancer | Q33330931 | ||
| High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas | Q33446023 | ||
| Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite | Q33553326 | ||
| Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues | Q33815515 | ||
| Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates | Q34086870 | ||
| A compendium of gene expression in normal human tissues | Q34107680 | ||
| The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition | Q34330487 | ||
| Structural basis of eukaryotic nitrate reduction: crystal structures of the nitrate reductase active site | Q34403682 | ||
| Cell biology of molybdenum | Q34539878 | ||
| Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro. | Q34652935 | ||
| Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer | Q34652960 | ||
| Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release | Q34656848 | ||
| Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology | Q35063758 | ||
| Hereditary xanthinuria type II associated with mental delay, autism, cortical renal cysts, nephrocalcinosis, osteopenia, and hair and teeth defects | Q35441188 | ||
| Gene expression profiling identifies clinically relevant subtypes of prostate cancer | Q35554359 | ||
| Human liver aldehyde oxidase: inhibition by 239 drugs | Q35610000 | ||
| Variation in gene expression patterns in human gastric cancers | Q35670324 | ||
| Enzyme-catalyzed activation of anticancer prodrugs | Q35682909 | ||
| In silico and in vitro pharmacogenetic analysis in mice | Q36140849 | ||
| Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues | Q36244121 | ||
| Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer | Q36570605 | ||
| Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin | Q36896845 | ||
| IPdR: a novel oral radiosensitizer | Q36916868 | ||
| Mammalian aldehyde oxidases: genetics, evolution and biochemistry. | Q37027355 | ||
| Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: generation and characterization of a knockout mouse | Q37033659 | ||
| Convergent neofunctionalization by positive Darwinian selection after ancient recurrent duplications of the xanthine dehydrogenase gene | Q37089373 | ||
| Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase | Q37177525 | ||
| Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney | Q37349768 | ||
| Enzymes depending on the pterin molybdenum cofactor: sequence families, spectroscopic properties of molybdenum and possible cofactor-binding domains. | Q37691606 | ||
| Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity | Q38305120 | ||
| Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray | Q38311648 | ||
| The mouse aldehyde oxidase gene: molecular cloning, chromosomal mapping and functional characterization of the 5'-flanking region. | Q38315449 | ||
| Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. | Q38324116 | ||
| Tandem orientation of duplicated xanthine dehydrogenase genes from Arabidopsis thaliana: differential gene expression and enzyme activities | Q39065916 | ||
| Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase | Q39599563 | ||
| Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets | Q40008951 | ||
| A genomic analysis of adult T-cell leukemia | Q40243714 | ||
| Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells | Q40291759 | ||
| Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas | Q40322109 | ||
| Bladder cancer outcome and subtype classification by gene expression | Q40414408 | ||
| Identification of aldehyde oxidase 1 and aldehyde oxidase homologue 1 as dioxin-inducible genes. | Q40467779 | ||
| The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury | Q40554667 | ||
| Gene expression analysis of prostate cancers | Q40664417 | ||
| Purification and characterization of multiple forms of rat liver xanthine oxidoreductase expressed in baculovirus-insect cell system | Q40700397 | ||
| Characterization of camptothecin-resistant chinese hamster lung cells | Q41619991 | ||
| The role of non-P450 enzymes in drug oxidation | Q41689734 | ||
| Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma | Q41918713 | ||
| Cyclophosphamide potentiation and aldehyde oxidase inhibition by phosphorylated aldehydes and acetals | Q42271796 | ||
| Activation of the human aldehyde oxidase (hAOX1) promoter by tandem cooperative Sp1/Sp3 binding sites: identification of complex architecture in the hAOX upstream DNA that includes a proximal promoter, distal activation sites, and a silencer element | Q42493009 | ||
| Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human | Q43451193 | ||
| High-resolution genome-wide mapping of genetic alterations in human glial brain tumors | Q43653580 | ||
| Tumor immunobiological differences in prostate cancer between African-American and European-American men. | Q44513168 | ||
| Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria | Q44613198 | ||
| Regulation and biochemistry of mouse molybdo-flavoenzymes. The DBA/2 mouse is selectively deficient in the expression of aldehyde oxidase homologues 1 and 2 and represents a unique source for the purification and characterization of aldehyde oxidase | Q44686501 | ||
| Potent inhibition of human liver aldehyde oxidase by raloxifene | Q44717288 | ||
| Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. | Q44885739 | ||
| Purification and biochemical characterization of simplified eukaryotic nitrate reductase expressed in Pichia pastoris | Q45007274 | ||
| Novel genes associated with malignant melanoma but not benign melanocytic lesions | Q46226262 | ||
| In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor | Q46399560 | ||
| Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver | Q46708972 | ||
| Influence of lipophilicity and carboxyl group content on the rate of hydroxylation of methotrexate derivatives by aldehyde oxidase | Q46784138 | ||
| Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats | Q46813345 | ||
| The dual substrate specificity of aldehyde oxidase 1 for retinal and acetaldehyde and its role in ABCA1 mediated efflux | Q46907759 | ||
| Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes | Q48384263 | ||
| Cloning, expression, and characterization of male cynomolgus monkey liver aldehyde oxidase | Q50467561 | ||
| Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status | Q50775513 | ||
| Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. | Q51955372 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 374-386 | |
| P577 | publication date | 2011-03-23 | |
| P1433 | published in | Drug Metabolism Reviews | Q5308857 |
| P1476 | title | Increasing recognition of the importance of aldehyde oxidase in drug development and discovery | |
| P478 | volume | 43 |
| Q38131587 | A mouse with humanized liver as an animal model for predicting drug effects and for studying hepatic viral infection: where to next? |
| Q38705494 | A simple litmus test for aldehyde oxidase metabolism of heteroarenes |
| Q37444937 | Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometry |
| Q38097076 | Aldehyde oxidase and its importance in novel drug discovery: present and future challenges |
| Q39016532 | An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery |
| Q64093921 | Application of Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP) |
| Q38799423 | Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance. |
| Q38151571 | Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics |
| Q38302281 | Comparison of minipig, dog, monkey and human drug metabolism and disposition |
| Q27684163 | Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design |
| Q58087792 | Effects of Phenothiazines on Aldehyde Oxidase Activity Towards Aldehydes and N-Heterocycles: an In Vitro and In Silico Study |
| Q90117416 | Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes |
| Q64113343 | Human aldehyde oxidase (hAOX1): structure determination of the Moco-free form of the natural variant G1269R and biophysical studies of single nucleotide polymorphisms |
| Q45753754 | Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions. |
| Q35579544 | Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions |
| Q57990921 | Insights into the structural determinants of substrate specificity and activity in mouse aldehyde oxidases |
| Q36072102 | Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase |
| Q51305174 | Interspecies variation in the metabolism of zoniporide by aldehyde oxidase. |
| Q54319308 | Metabolism of xenobiotics by aldehyde oxidase. |
| Q38802917 | Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro-In Vivo Comparisons |
| Q38860432 | Modern advances in heterocyclic chemistry in drug discovery |
| Q37125313 | Mouse aldehyde-oxidase-4 controls diurnal rhythms, fat deposition and locomotor activity |
| Q38318607 | Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases. |
| Q27703955 | Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms |
| Q36736202 | Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase |
| Q38066611 | Strategies for a comprehensive understanding of metabolism by aldehyde oxidase |
| Q27702038 | Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase |
| Q57097682 | Structure and evolution of vertebrate aldehyde oxidases: from gene duplication to gene suppression |
| Q38751930 | Structure and function of mammalian aldehyde oxidases |
| Q43645015 | Structure-based investigation of rat aldehyde oxidase inhibition by flavonoids |
| Q27673709 | The First Mammalian Aldehyde Oxidase Crystal Structure: INSIGHTS INTO SUBSTRATE SPECIFICITY |
| Q33746582 | The four aldehyde oxidases of Drosophila melanogaster have different gene expression patterns and enzyme substrate specificities |
| Q28258167 | The impact of single nucleotide polymorphisms on human aldehyde oxidase |
| Q38176051 | The role of drug metabolizing enzymes in clearance |
Search more.